Reduced pulmonary clearance of endothelin-1 contributes to the increase of circulating levels in heart failure secondary to myocardial infarction

被引:58
作者
Dupuis, J [1 ]
Rouleau, JL [1 ]
Cernacek, P [1 ]
机构
[1] Montreal Heart Inst, Dept Med, Res Ctr, Montreal, PQ H1T 1C8, Canada
关键词
endothelin; heart failure; pulmonary heart disease; myocardial infarction; lung;
D O I
10.1161/01.CIR.98.16.1684
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-The pulmonary vascular bed is a major site for endothelin-l (ET-1) clearance. A reduced clearance could contribute to the increase in circulating ET-1 levels found in heart failure (HF). We therefore evaluated the effect of HF on pulmonary ET-1 clearance and on plasma ET-1 concentrations. Methods and Results-Rats with myocardial infarction (n=24) were compared with sham-operated rats (n=22). The lungs were isolated and perfused at a constant flow rate of 10 mL/min. Pulmonary ET-1 clearance was measured by the single-bolus indicator-dilution technique with I-125-labeled ET-I. Infarct rats developed MF with mild pulmonary hypertension. ET-1 extraction was reduced by HF from 63 +/- 1.5% to 41 +/- 4.5% (mean+/-SEM, P<0.001). Mixed venous (MV) and aortic ET-1 levels doubled with HF. There was a plasma ET-1 gradient across the lungs of sham rats (MV-aortic levels, 0.21+/-0.12 pg/mL) but not in lungs of HF rats (0.01+/-0.17 pg/mL). Plasma ET-I levels correlated closely and inversely with ET-1 extraction (P<0.001). Conclusions-HF is associated with reduced pulmonary ET-I clearance that contributes to the increase in circulating levels.
引用
收藏
页码:1684 / 1687
页数:4
相关论文
共 24 条
[1]  
ANGGARD E, 1989, J CARDIOVASC PHARM, V13, pS46
[2]  
Cernacek P., 1995, Clinical and Investigative Medicine, V18, pB12
[3]   PLASMA ENDOTHELIN CORRELATES WITH THE EXTENT OF PULMONARY-HYPERTENSION IN PATIENTS WITH CHRONIC CONGESTIVE-HEART-FAILURE [J].
CODY, RJ ;
HAAS, GJ ;
BINKLEY, PF ;
CAPERS, Q ;
KELLEY, R .
CIRCULATION, 1992, 85 (02) :504-509
[4]   THE POTENTIAL ROLE OF ENDOTHELIN AS A VASOCONSTRICTOR SUBSTANCE IN CONGESTIVE-HEART-FAILURE [J].
CODY, RJ .
EUROPEAN HEART JOURNAL, 1992, 13 (11) :1573-1578
[5]  
DENUCCI G, 1988, P NATL ACAD SCI USA, V85, P9797
[6]   Pulmonary clearance of circulating endothelin-1 in dogs in vivo: Exclusive role of ET(B) receptors [J].
Dupuis, J ;
Goresky, CA ;
Fournier, A .
JOURNAL OF APPLIED PHYSIOLOGY, 1996, 81 (04) :1510-1515
[7]   PULMONARY REMOVAL AND PRODUCTION OF ENDOTHELIN IN THE ANESTHETIZED DOG [J].
DUPUIS, J ;
GORESKY, CA ;
STEWART, DJ .
JOURNAL OF APPLIED PHYSIOLOGY, 1994, 76 (02) :694-700
[8]   Human pulmonary circulation is an important site for both clearance and production of endothelin-1 [J].
Dupuis, J ;
Stewart, DJ ;
Cernacek, P ;
Gosselin, G .
CIRCULATION, 1996, 94 (07) :1578-1584
[9]   CLEARANCE OF CIRCULATING ENDOTHELIN-1 BY ET(B) RECEPTORS IN RATS [J].
FUKURODA, T ;
FUJIKAWA, T ;
OZAKI, S ;
ISHIKAWA, K ;
YANO, M ;
NISHIKIBE, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 199 (03) :1461-1465
[10]   EVIDENCE FOR ENDOTHELIN-1-MEDIATED VASOCONSTRICTION IN SEVERE CHRONIC HEART-FAILURE [J].
KIOWSKI, W ;
SUTSCH, G ;
HUNZIKER, P ;
MULLER, P ;
KIM, J ;
OECHSLIN, E ;
SCHMITT, R ;
JONES, R ;
BERTEL, O .
LANCET, 1995, 346 (8977) :732-736